MétaCan
Menu
Back to cohort
Record W3185170835 · doi:10.1016/j.lanepe.2021.100181

The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey

2021· article· en· W3185170835 on OpenAlexaff
Simon Mark Dahl Baunwall, Elisabeth M. Terveer, Jens Frederik Dahlerup, Christian Erikstrup, Perttu Arkkila, Maria J. G. T. Vehreschild, Gianluca Ianiro, Antonio Gasbarrini, Harry Sokol, Patrizia Kump, Reetta Satokari, Danny De Looze, Séverine Vermeire, Radislav Nakov, Jan Březina, Morten Helms, Jens Kjeldsen, Anne Rode, Sabrina Just Kousgaard, Laurent Alric, Caroline Trang-Poisson, Julien Scanzi, Alexander Link, Andreas Stallmach, Juozas Kupčinskas, Peter Holger Johnsen, Kjetil Garborg, Eugenia Sánchez Rodríguez, Lena Serrander, Robert J. Brummer, Simon Goldenberg, Benjamin H. Mullish, Horace R. Williams, Tariq Iqbal, Cyriel Y. Ponsioen, Ed J. Kuijper, Giovanni Cammarota, Josbert J. Keller, Christian Lodberg Hvas

Bibliographic record

VenueThe Lancet Regional Health - Europe · 2021
Typearticle
Languageen
FieldMedicine
TopicClostridium difficile and Clostridium perfringens research
Canadian institutionsHotel Dieu Hospital
FundersNIHR Imperial Biomedical Research CentreLundbeckfondenImperial College Healthcare NHS TrustNational Institute for Health and Care ResearchInnovationsfondenImperial College LondonNordForskNordisk MinisterrådLandspítali HáskólasjúkrahúsTakeda Pharmaceutical CompanyPfizer
KeywordsFecal bacteriotherapyTransplantationMedicineBiologyGeographyMicrobiologyInternal medicineClostridium difficile

Abstract

fetched live from OpenAlex

BACKGROUND: Faecal microbiota transplantation (FMT) is an emerging treatment modality, but its current clinical use and organisation are unknown. We aimed to describe the clinical use, conduct, and potential for FMT in Europe. METHODS: We invited all hospital-based FMT centres within the European Council member states to answer a web-based questionnaire covering their clinical activities, organisation, and regulation of FMT in 2019. Responders were identified from trials registered at clinicaltrials.gov and from the United European Gastroenterology (UEG) working group for stool banking and FMT. FINDINGS: infection (CDI) as indication, 791 (42%) with experimental indications, and 6 (0•3%) unaccounted for. Adjusted to population size, 0•257 per 100,000 population received FMT for CDI and 0•189 per 100,000 population for experimental indications. With estimated 12,400 (6,100-28,500) annual cases of multiple, recurrent CDI and indication for FMT in Europe, the current European FMT activity covers approximately 10% of the patients with indication. The participating centres demonstrated high safety standards and adherence to international consensus guidelines. Formal or informal regulation from health authorities was present at 21 (68%) centres. INTERPRETATION: FMT is a widespread routine treatment for multiple, recurrent CDI and an experimental treatment. Embedded within hospital settings, FMT centres operate with high standards across Europe to provide safe FMT. A significant gap in FMT coverage suggests the need to raise clinical awareness and increase the FMT activity in Europe by at least 10-fold to meet the true, indicated need. FUNDING: NordForsk under the Nordic Council and Innovation Fund Denmark (j.no. 8056-00006B).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.019

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0020.003
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.210
GPT teacher head0.370
Teacher spread0.159 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations96
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueThe Lancet Regional Health - EuropeSame topicClostridium difficile and Clostridium perfringens researchFrench-language works237,207